Chiocca EA - Search Results

1

A phase I trial of Ad.hIFN-beta gene therapy for glioma.

Chiocca EA, Smith KM, McKinney B, Palmer CA, Rosenfeld S, Lillehei K, Hamilton A, DeMasters BK, Judy K, Kirn D. Chiocca EA, et al. Mol Ther. 2008 Mar;16(3):618-26. doi: 10.1038/sj.mt.6300396. Epub 2008 Jan 8. Mol Ther. 2008. PMID: 18180770 Free article. Clinical Trial.

2

Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector.

Herrlinger U, Kramm CM, Aboody-Guterman KS, Silver JS, Ikeda K, Johnston KM, Pechan PA, Barth RF, Finkelstein D, Chiocca EA, Louis DN, Breakefield XO. Herrlinger U, et al. Among authors: chiocca ea. Gene Ther. 1998 Jun;5(6):809-19. doi: 10.1038/sj.gt.3300643. Gene Ther. 1998. PMID: 9747461

3

The complement response against an oncolytic virus is species-specific in its activation pathways.

Wakimoto H, Ikeda K, Abe T, Ichikawa T, Hochberg FH, Ezekowitz RA, Pasternack MS, Chiocca EA. Wakimoto H, et al. Among authors: chiocca ea. Mol Ther. 2002 Mar;5(3):275-82. doi: 10.1006/mthe.2002.0547. Mol Ther. 2002. PMID: 11863417 Free article.

4

Intra-arterial delivery of p53-containing adenoviral vector into experimental brain tumors.

Abe T, Wakimoto H, Bookstein R, Maneval DC, Chiocca EA, Basilion JP. Abe T, et al. Among authors: chiocca ea. Cancer Gene Ther. 2002 Mar;9(3):228-35. doi: 10.1038/sj.cgt.7700437. Cancer Gene Ther. 2002. PMID: 11896438

5

Effects of innate immunity on herpes simplex virus and its ability to kill tumor cells.

Wakimoto H, Johnson PR, Knipe DM, Chiocca EA. Wakimoto H, et al. Among authors: chiocca ea. Gene Ther. 2003 Jun;10(11):983-90. doi: 10.1038/sj.gt.3302038. Gene Ther. 2003. PMID: 12756419 Review.

6

Viral therapy for glioblastoma.

Chiocca EA, Aghi M, Fulci G. Chiocca EA, et al. Cancer J. 2003 May-Jun;9(3):167-79. doi: 10.1097/00130404-200305000-00005. Cancer J. 2003. PMID: 12952302 Review.

7

Altered expression of antiviral cytokine mRNAs associated with cyclophosphamide's enhancement of viral oncolysis.

Wakimoto H, Fulci G, Tyminski E, Chiocca EA. Wakimoto H, et al. Among authors: chiocca ea. Gene Ther. 2004 Jan;11(2):214-23. doi: 10.1038/sj.gt.3302143. Gene Ther. 2004. PMID: 14712306 Free PMC article.

8

Infectious delivery of the 132 kb CDKN2A/CDKN2B genomic DNA region results in correctly spliced gene expression and growth suppression in glioma cells.

Inoue R, Moghaddam KA, Ranasinghe M, Saeki Y, Chiocca EA, Wade-Martins R. Inoue R, et al. Among authors: chiocca ea. Gene Ther. 2004 Aug;11(15):1195-204. doi: 10.1038/sj.gt.3302284. Gene Ther. 2004. PMID: 15164098

9

A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting.

Chiocca EA, Abbed KM, Tatter S, Louis DN, Hochberg FH, Barker F, Kracher J, Grossman SA, Fisher JD, Carson K, Rosenblum M, Mikkelsen T, Olson J, Markert J, Rosenfeld S, Nabors LB, Brem S, Phuphanich S, Freeman S, Kaplan R, Zwiebel J. Chiocca EA, et al. Mol Ther. 2004 Nov;10(5):958-66. doi: 10.1016/j.ymthe.2004.07.021. Mol Ther. 2004. PMID: 15509513 Free article. Clinical Trial.

10

Genetic strategies for brain tumor therapy.

Lawler SE, Peruzzi PP, Chiocca EA. Lawler SE, et al. Among authors: chiocca ea. Cancer Gene Ther. 2006 Mar;13(3):225-33. doi: 10.1038/sj.cgt.7700886. Cancer Gene Ther. 2006. PMID: 16138122 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

458 results

Search Page

Filters